Skip to content
healthcare.dev

ARISTADA

NDC 65757-404, aripiprazole lauroxil, injection, suspension, extended release, from Alkermes, Inc..

Product NDC
65757-404
Status
Listed
Labeler
Alkermes, Inc.
Dosage form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA207533
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65757-404 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ARIPIPRAZOLE LAUROXIL1064 mg/3.9mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
65757-404-03657570404031 SYRINGE in 1 CARTON (65757-404-03) / 3.9 mL in 1 SYRINGE
65757-404-04657570404041 SYRINGE in 1 CARTON (65757-404-04) / 3.9 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/17a8d11b-73b0-4833-a0b4-cf1ef85edefb
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=65757-404
  • NADAC price for package 65757040403

    GET /v1/drugs/nadac/65757040403

Use it

Look up 65757-404 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65757-404 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65757-404. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.